Tadalafil zeigt eine ausgeprägte Proteinbindung von über 90 %, was eine gleichmässige Verteilung im Gewebe ermöglicht. Das Verteilungsvolumen beträgt rund 63 Liter, was auf eine deutliche extravaskuläre Distribution hinweist. Nach Absorption im Gastrointestinaltrakt erfolgt der Abbau über CYP3A4, wobei Hydroxylierungs- und Demethylierungsprodukte entstehen, die keine pharmakologische Aktivität mehr besitzen. Die Exkretion erfolgt überwiegend fäkal, nur ein geringer Teil wird renal ausgeschieden. Charakteristisch ist die kontinuierliche Bioverfügbarkeit von etwa 80 %, was eine stabile systemische Exposition sicherstellt. Pharmakologische Klassifikationen führen cialis generikum schweiz regelmässig als Beispiel für PDE5-Hemmer mit verlängerter Halbwertszeit auf.

Affirmation

References
Ambrosini A, de Noordhout A und Sandor PS and Schoenen J (2003): Electrophysiological
studies in migraine: a comprehensive review of their interest and limitations. Cephalalgia causes high intensity dependence of auditory evoked cortical potentials in migraine. Brain 126, 2009-2015 Ashina M, Bendtsena L, Jensena R, Schifterb S and Olesen J (2000): Evidence for increased plasma levels of calcitonin gene-related peptide in migraine outside of attacks. Pain 86, 133-138 Barbiroli B, Montagna P, Cortelli P, Funicello R, Iotti S, Monari L et al (1992): Abnormal brain and muscle energy metabolism shown by 31P magnetic resonance spectroscopy in patients affected by migraine with aura. Neurology 1209, 115–1214 a (2004): Activation of 5-HT(1B/1D) receptor in the periaqueductal gray inhibits nociception. Ann. Neurol. 56, 371-381 Battelli L, Black KR und Wray SH (2002): Transcranial magnetic stimulation of visual area V5 in migraine. Neurology 58, 1066–1069 Bellamy J, Bowen E, Russo A and Durham P (2006): Nitric oxide regulation of calcitonin gene-related peptide gene expression in rat trigeminal ganglia neurons. Eur. J. Neurosci. 23, 2057–2066 Bocos C, Gottlicher M, Gearing K, Banner C, Enmark E, Teboul M et al (1995): Fatty acid activation of peroxisome proliferator-activated receptor (PPAR). J. Steroid. Biochem. Mol. Biol. 53, 467–473 Bough KJ und Rho JM. Anticonvulsant mechanisms of the ketogenic diet (2007): Epilepsia Bough KJ, Wetherington J, Hassel B, Pare JF, Gawryluk JW, Greene JG et al (2006): Mitochondrial biogenesis in the anticonvulsant mechanism of the ketogenic diet. Ann. Neurol. 60, 223–235 Buchanan TM and Ramadan NM (2006): Prophylactic pharmacotherapy for migraine aspects of regulation of mitochondrial activity by fenofibrate and fasti 482, 71-74 arcia Y, Plotkine M and Marchand-Leroux C (2007): Neurological recovery-promoting, anti-inflammatory, and anti-oxidative effects afforded by fenofibrate, a PPAR alpha agonist, in traumatic brain injury. 24, 1119-1131 Chung SW, Kang BY, Kim SH, Pak YK, Cho D, Trinchieri G et al (2000): Oxidized low density lipoprotein inhibits interleukin-12 production in lipopolysaccharide-activated mouse macrophages via direct interactions between peroxisome proliferator-activated receptor-gamma and nuclear factor-kappa B. J. Biol. Chem. 275, 32681–32687 ketogenic diet in children, adolescents and young adults with refractory epilepsy: an Italian multicentric experience 48, 221-227 Cullingford TE, Bhakoo K, Peuchen S a (1998): Distribution of mRNAs encoding the peroxisome proliferator-activated receptor (PPAR) - Ketogenic diet in migraine – a new approach for treatment ? alpha, -beta, and -gamma and the retinoid X receptor (RXR) -alpha, -beta, and -gamma in rat central nervous system. J. Neurochem. 70, 1366-1375 Cullingford TE, Eagles DA and Sato H (2002): The ketogenic diet upregulates expression of the gene encoding the key ketogenic enzyme mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase in rat brain. Epilepsy Res. 49, 99-107 D'Amico D, Ferraris A, Catania A, Carlin A, Leone M, Attanasio A and Bussone G (1998): Increased basal nitric oxide plasma concentration in migraine. EOS 13, 109-111 Dahlin M, Elfving A, Ungerstedt U and Amark P (2005): The ketogenic diet influences the levels of excitatory and inhibitory amino acids in the CSF in children with refractory epilepsy. Epilepsy Res. 48, 115-125 Delerive P, De Bosscher K, Vanden Berghe W, Fruchart JC, Haegeman G and Staels B (2002): DNA binding-independent induction of IkappaBalpha gene transcription by PPARalpha. Mol. Endocrinol. 16, 1029 –1039 Delerive P, Gervois P, Fruchart JC and Staels B (2000): Induction of IkappaBalpha expression as a mechanism contributing to the anti-inflammatory activities of peroxisome proliferator-activated receptor-alpha activators. J. Biol. Chem. 275, 36703–36707 Dodick D und Silberstein S (2006): Central sensitization theory of migraine: clinical Dodick DW and Silberstein SD (2007): Migraine prevention. Pract .Neurol. 7, 383–393 De Vivo DC, Leckie MP, Ferrendelli JS and McDougal DB (1978): Chronic ketosis and cerebral metabolism. Ann. Neurol. 3, 331-337 Ebersberger A (2002): Pathophysiologie der Migräne. Anaesthesist 5, 661–667 Escher P and Wahli W (2000): Peroxisome proliferator-activated receptors: insight into multiple cellular functions. Mutat. Res. 448, 121–138 Forman BM, Chen J and Evans RM (1997): Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta. Proc. Natl. Acad. Sci. USA 94, 4312–4317 Freeman JM, Kossoff EH and Hartman AL (2007): The ketogenic diet: one decade later. Fuenmayor LD and Garcia S (2002): The effect of fasting on 5-hydroxytryptamine metabolism in brain regions of the albino rat. Br J Pharmacol 1984; 83: 375-362 Fusayasu E , Kowa H, Takeshima T, Nakaso K and Nakashima K (2007): Increased plasma substance P and CGRP levels, and high ACE activity in migraineurs during headache-free periods. Pain 128, 209–214 Goadsby PJ, Lipton RB and Ferrari MD (2002): Migraine - current understanding and treatment. N. Engl. J. Med. 346, 257-270 Gutschalk A, Kollmar F, Mohr A, Henze M, Ille N, Schwaninger M et al (2002): Multimodal functional imaging of prolonged neurological deficits in a patient suffering from familial hemiplegic migraine. Neurosci. Lett. 332, 115–118 Hasselbach SG, Knudsen GM, Jakobsen J, Hageman LP, Holm S and Paulson OB (1994): Brain metabolism during short-term starvation in humans. 14, 125–131 Issemann I and Green S (2002): Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature 1990; 347: 645–650 Jabre MG and Bejjani BP (2006): Treatment of Parkinson disease with diet-induced hyperketonemia: a feasibility study. Neurology 66, 617 Ketogenic diet in migraine – a new approach for treatment ? Jacome DE (2001): Hypoglycemia rebound migraine. Headache 41, 895–898 Juge-Aubry C, Pernin A, Favez T, Burger AG, Wahli W, Meier CA et al (1997): Desvergne,
DNA binding properties of peroxisome proliferator-activated receptor subtypes on various natural peroxisome proliferator response elements. Importance of the 50-flanking region. J. Biol. Chem. 272, 25252–25259 (2007): The triggers or precipitants of the acute migraine attac 27, peroxisome proliferator-activated receptor alpha regulates amino acid metabolism. 15, 1971-1978 therapy for intractable epilepsy. Neurology 23, 1789-1791 modified Atkins diet is effective for the treatment of intractable pediatric epilepsy. Epilepsia 47, 421-424 Lang E, Kaltenhäuser M, Neundörfer B and Seidler S (2004): Hyperexcitability of the primary somatosensory cortex in migraine - a magnetoencephalographic study. Brain 127, 2459–2469 Latruffe N, Cherkaoui-Malki M, Nicolas-Frances V, Clemencet MC, Janin B and Berlot J (2000): Regulation of the peroxisomal β-oxidation-dependent pathway by peroxisome proliferator-activated receptor α and kinases. Biochem. Pharmacol. 60, 1027–1032 Le May C, Pineau T, Bigot K, Kohla C, Girarda J and Pégorier JP (2000): Reduced hepatic fatty acid oxidation in fasting PPARalpha null mice is due to impaired mitochondrial hydroxymethylglutaryl-CoA synthase gene expression. FEBS letters 475, 163-166 Leonardi M, Steiner T, Scher AT and Lipton RB (2005): The global burden of migraine: measuring disability in headache disorders with WHO’s Classification of Functioning, Disability and Health (ICF). J. Headache Pain 6, 429–440 Leone TC, Weinheimer CJ and Kelly, DP (1999): A critical role for the peroxisome proliferator-activated receptor alpha (PPARalpha) in the cellular fasting response: the PPARalpha-null mouse as a model of fatty acid oxidation disorders. Proc. Natl. Acad. Sci. USA 96, 7473-7478 Kantak KM, Wayner MJ and Stein JM (1978): Effects of various periods of food deprivation on serotonin synthesis in the lateral hypothalamus. Pharmacol Biochem Behav. 9, 534-541 ketogenic diet: adolescents can do it, too. Epilepsia 44, 847-851 Magisretti P and Pellerin L (1999): Cellular mechanisms of brain energy metabolism and their relevance to functional brain imaging. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 354, 1155-1163 Margareta T, Nehlig A and Sonnewald U (2006): Neuronal-glial interactions in rats fed a ketogenic diet. Neurochem. Int .48, 498-507 Marsters JB, Mortimer MJ and Hay KM (1986): Glucose and diet in the fasting migraineur. Mattson MP, Duan W and Guo Z (2003): Meal size and frequency affect neuronal plasticity and vulnerability to disease: cellular and molecular mechanisms. J. Neurochem. 84, 417–431 Ketogenic diet in migraine – a new approach for treatment ? Matsutani K, Tsuruoka, M, Shinya A, Furuya R and Kawawa T (2000): Stimulation of the locus coeruleus suppresses trigeminal sensorimotor function in the rat. Brain. Res. Bull. 53, 827-832; zit in: Peroutka 2004 McCarthy LC, Hosford DA, Riley JH, Bird MI, White NJ, Hewett DR et al (2001): Single- nucleotide polymorphism alleles in the insulin receptor gene are associated with typical migraine. Genomoics 78, 135–149 Montagna P, Cortelli P, Monari L, Pierangeli G, Parchi P, Lodi R et al (1994): 31P-magnetic resonance spectroscopy in migraine without aura. Neurology 44, 666–669 Moskowitz MA, Bolay H and Dalkara T (2004): Deciphering migraine mechanisms: clues from familial hemiplegic migraine genotypes. Ann. Neurol. 55, 276–280 Neubauer G and Ujlaky RP (2002): Migräne - eine Volkskrankheit und ihre Kosten. Pharm Pan JW, Bebin EM, Chu WJ and Hetherington HP (1999): Ketosis and Epilepsy: 31P Spectroscopic imaging at 4.1 T. Epilepsia 40, 703–707 Peroutka S (2004): Migraine: a chronic sympathetic nervous sytem disorder. Headache 44, a(2005): Low-glycemic-index treatment: a liberalized ketogenic diet for treatment of intractable epileps 65, 1810-1812 Pirke KM, Broocks A, Wilckens R a U (1993): Starvation-induced hyperactivity in the rat: the role of endocrine and neurotransmitter changes. Neurosci. Biobehav. Rev .17, 287-294 (1997): Intensity dependence of the cortical auditory evoked potentials as a surrogate marker of central nervous system serotonin transmission in man: demonstration of a central effect for the 5HT1B/1D agonist zolmitriptan (311C90, Zomig). Cephalalgia 17, 849-854 Sacquegna T, Lodi R, De Carolis P, Tinuper P, Cortelli P, Zaniol P et al (1992): Brain energy metabolism studied by 31P-MR spectroscopy in a case of migraine with prolonged aura. Acta Neurol. Scand. 86, 376–380 Sakai Y, Dobson C, Diksic M, Aubé M and Hamel E (2008): Sumatriptan normalizes the migraine attack-related increase in brain serotonin synthesis. Neurology 70, 431-439 Sang CN, Ramadan NM, Wallihan RG, Chappell AS, Freitag FG and Smith TR et al (2004): LY293558, a novel AMPA/GluR5 antagonist, is efficacious and well-tolerated in acute migraine. Cephalalgia 24, 596–602 Sankar R and Sotero de Menezes M (1999): Metabolic and endocrine aspects of the ketogenic Sasa M, Fujimoto S, Igarashi S, Munekiyo K and Takaori S (1979): Microiontophoretic studies on noradrenergic inhibition from locus coeruleus of spinal trigeminal nucleus neurons. J. Pharmacol. Exp. Ther. 210, 311-315; zit in: Peroutka 2004 Schwartz MW, Figlewicz DP, Baskin DG, Woods SC, Porte D Jr et al (1992): Insulin in the brain: a hormonal regulator of energy balance. Endocr. Rev. 13, 387–414 Schweiger U, Broocks A, Tuschl RJ and Pirke KM (1989): Serotonin turnover in rat brain during semistarvation with high protein and high carbohydrate diets. J. Neural. Transm. 77, 131-139 Sethi S, Ziouzenkova O, Wagner DD, Plutzky J and Mayadas TN (2002): Oxidized omega-3 fatty acids in fish oil inhibit leukocyte-endothelial interactions through activation of PPAR alpha. Blood 100, 1340–1346 Ketogenic diet in migraine – a new approach for treatment ? Shalev A, Siegrist-Kaiser CA, Yen PM, Whali W, Burger AG, ChinWW and Meier CA (1996): The peroxisome proliferator-activated receptor a is a phosphoprotein: regulation by insulin. Endocrinology 137, 4499–4502 Sheikh K, Camejo G, Lanne B, Halvarsson T, Landergren MR and Oakes ND (2007): Beyond lipids, pharmacological PPAR-activation has important effects on amino acid metabolism as studied in the rat. Am. J. Physiol. Endocrinol. Metab. 292, 1157–1165 Shields KG and Goadsby PJ (2006): Serotonin receptors modulate trigeminovascular responses in ventroposteromedial nucleus of thalamus: A migraine target? Neurobiol. Dis. 23, 491– 501 Silberstein SD (2004): Migraine. Lancet 363, 381–391 Silver IA and Erecinsyca M (1997): Energetic demands of the Na/K ATPase in mammalian diet for intractable epilepsy in adults: preliminary results. Epilepsia 40, 1721-1726 Sparaco M, Feleppa M, Lipton RB, Rapoport AM and Bigal ME (2006): Mitochondrial dysfunction and migraine: evidence and hypotheses. Cephalalgia 26, 361–372 Storer RJ, Akerman S, Shields KG and Goadsby PJ (2004): GABAA receptor modulation of trigeminovascular nociceptive neurotransmission by midazolam is antagonized by flumazenil. Brain Res.1013, 188–193 Strahlman RS (2006): Can ketosis help migraine sufferers? A case report. Headache 46, 182– Sullivan PG, Rippy NA, Dorenbos K, Concepcion RC, Agarwal AK and Rho JM (2004): The ketogenic diet increases mitochondrial uncoupling protein levels and activity. Ann. Neurol. 55, 576–580 Szot P, Weinshenker D, Rho JM, Storey TM and Schwartzkroin PA (2001): Norepinephrine is required for the anticonvulsant effect of the ketogenic diet. Brain Res. Dev. Brain. Res. 129, 211–214 Taha AY, Ryan MA and Cunnane SC (2005): Despite transient ketosis, the classic high-fat ketogenic diet induces marked changes in fatty acid metabolism in rats. Metabolism 54, 1127–1132 Taha A, Ryan M and Cunnane S (2005): Despite transient ketosis, the classic high-fat ketogenic diet induces marked changes in fatty acid metabolism in rats. Metabolism 54, 1127– 1132 Theodore WH (2003): Does serotonin play a role in epilepsy? Epilepsy Curr. 3, 173–177 Van der Auwera I, Wera S, Van Leuven F and Henderson ST (2005): A ketogenic diet reduces amyloid beta 40 and 42 in a mouse model of Alzheimer’s disease. Nutr. Metab. (Lond.) 2, 28 Volek JS, Sharman MJ, Love D, Avery N, Scheett AG and Kraemer W (2002): Body composition and hormonal responses to a carbohydrate restricted diet. Metabolism 51, 864–870 Weiyuan M, Berg J and Yellen G (2007): Ketogenic diet metabolites reduce firing in central neurons by opening KATP channels. J. Neurosc. 27, 3618-3625 Welch KM (2005): Brain hyperexcitability: the basis for antiepileptic drugs in migraine Ketogenic diet in migraine – a new approach for treatment ? Welch KM, Levine SR, D'Andrea G, Schultz LR, Helpern JA (1989): Preliminary observations on brain energy metabolism in migraine studied by in vivo phosphorus 31 NMR spectroscopy. Neurology 39, 538–541 Wolf NI, Bast T and Surtees R (2005): Epilepsy in inborn errors of metabolism. Epileptic. Xiao DQ, Zhua JX, Tanga JS and Jia H (2005): GABAergic modulation mediates antinociception produced by serotonin applied into thalamic nucleus submedius of the rat. Brain Research 1057, 161 – 167 Xu J, Storer P, Chavis J, Racke M and Drew P (2005): Agonists for the peroxisome proliferator-activated receptor-alpha and the retinoid X receptor inhibit inflammatory responses of microglia. J. Neurosci. Res. 81, 403–411 Yudkoff M, Daikhin Y, Nissim I, Grunstein R and Nissim I (1997): Effects of ketone bodies on astrocyte amino acid metabolism. J. Neurochem. 69, 682-692 Yudkoff M, Daikhin Y, Nissim I, Lazarow A, Nissim I (2001): Ketogenic Diet, amino acid metabolism, and seizure control. J. Neurosci. Res. 66: 931–940 Ziegler DR, Ribeiro LC, Hagenn M, Siqueira IR, Araújo E, Torres IL et al (2003): Ketogenic diet increases glutathione peroxidase activity in rat hippocampus. Neurochem. Res. 28, 1793–1797 Zhao Z, Lange DJ, Voustianiouk A, MacGrogan D, Ho L, Suh J et al (2006): A ketogenic diet as a potential novel therapeutic intervention in amyotrophic lateral sclerosis. BMC Neurosci. 7, 29

Source: http://www.lanutri.de/media/Publikation_Autoren.pdf